NCT06119724Active, not recruiting
Bipolar Enbloc Versus Thulium-Yag Enbloc Resection of Bladder Tumors
Bipolar Enbloc Versus Thulium-Yag Enbloc Resection Of Bladder Tumors: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 29 Nov 2024
Brief summary (registry, in English)
Prospective controlled study randomized comparing bipolar enbloc versus thulium enbloc for bladder tumours
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 17 Jun 2023
- Start date
- 11 Jun 2023
- Primary completion date
- 10 Nov 2025
- Lead sponsor
- Menoufia University
- Diseases
- Bladder cancer
- NCT number
- NCT06119724
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 11 Jun 2023 to the primary completion date, 10 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Inclusion criteria:
- Patients with NMIBC
- Bladder tumors\<4 cm in CT.
- Resectable bladder tumors.
- Age \<80 years.
- Exclusion criteria :
- Bladder tumours \> 4cm .
- Metastatic bladder tumors.
- Patients with carcinoma in situ CIS .
- Patients with coagulopathies.
- Domal bladder tumors.
Age in the registry: 25 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Menoufia University Hospital Coordinator of this site? Confirm its status | Shibīn al Kawm | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.